Aviva Holdings’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-441,649
Closed -$17.7M 6
2019
Q1
$17.7M Sell
441,649
-23,000
-5% -$923K 3.89% 4
2018
Q4
$21.4M Sell
464,649
-735,451
-61% -$33.8M 6.74% 4
2018
Q3
$53.2M Hold
1,200,100
14.21% 3
2018
Q2
$47M Buy
1,200,100
+1,032,513
+616% +$40.5M 7.64% 4
2018
Q1
$12.1M Sell
167,587
-121,513
-42% -$8.79M 4.92% 4
2017
Q4
$14.5M Hold
289,100
8.49% 4
2017
Q3
$14.5M Sell
289,100
-51,000
-15% -$2.56M 7.53% 3
2017
Q2
$15.7M Hold
340,100
9.92% 2
2017
Q1
$12M Buy
+340,100
New +$12M 5.6% 3